[{"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["CHILDRENS ROBITUSSIN HONEY COUGH AND CHEST CONGESTION DM"], "generic_name": ["DEXTROMETHORPHAN HBR, GUAIFENESIN"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0031-8760"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["DEXTROMETHORPHAN HYDROBROMIDE", "GUAIFENESIN"], "rxcui": ["1790650"], "spl_id": ["80b851fe-4f4e-460c-8a7b-dbe2e8fbe072"], "spl_set_id": ["b87f700e-3414-463c-80d4-c3dbca89a488"], "package_ndc": ["0031-8760-12", "5030031876"], "is_original_packager": [true], "nui": ["N0000193956", "N0000008867", "N0000009560"], "pharm_class_epc": ["Expectorant [EPC]"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "unii": ["9D2RTI9KYH", "495W7451VQ"]}, "product_type": "Drugs", "event_id": "85848", "recalling_firm": "Glaxosmithkline Consumer Healthcare Holdings", "address_1": "184 Liberty Corner Rd", "address_2": "N/A", "postal_code": "07059-6796", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US", "recall_number": "D-1361-2020", "product_description": "Childrens Robitussin Honey Cough and Chest Congestion DM, dextromethorphan (cough suppressant), guaifenesin (expectorant), 4 FL OZ. bottle (118 mL), Distributed by: Pfizer, Madison, NJ 07940 USA, UPC: 50300318760128, NDC: 0031-8760-12.", "product_quantity": "132,336 bottles", "reason_for_recall": "Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.", "recall_initiation_date": "20200616", "center_classification_date": "20200626", "termination_date": "20220603", "report_date": "20200708", "code_info": "Lot #s: 02177, 02178, Exp. 01/31/2022"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "22 ml", "code_info": "All lots distributed between November 2014 and May 2015;  03232015@18, 6/21/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Hydromorphone 35 mg/ml + Bupivacaine 4 mg/ml Intrathecal Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1673-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["REGENER-EYES"], "generic_name": ["REGENER-EYES"], "manufacturer_name": ["Regenerative Processing Plant, LLC"], "product_ndc": ["82305-003"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["GLYCERIN"], "rxcui": ["2540675", "2609932"], "spl_id": ["30cb2afc-827d-5e43-e063-6294a90a50e3"], "spl_set_id": ["e689001a-3640-1d45-e053-2995a90a4032"], "package_ndc": ["82305-003-01", "82305-003-02"], "is_original_packager": [true], "nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "unii": ["PDC6A3C0OX"]}, "product_type": "Drugs", "event_id": "95912", "recalling_firm": "Regenerative Processing Plant, LLC", "address_1": "34176 Us Highway 19 N", "address_2": "", "postal_code": "34684-2144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0153-2025", "product_description": "PROFESSIONAL Regener-Eyes, Ophthalmic Solution (glycerin 0.5%) , 3mL bottles, Distributed by: Regener-Eyes, Tampa, FL; Manufactured by: Regenerative Processing Plant, LLC, 34176 US HWY 19N, FL, NDC 82305-003-01", "product_quantity": "59275", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20241210", "center_classification_date": "20241217", "termination_date": "20250627", "report_date": "20241225", "code_info": "Lot #: P120522A, Exp. Date 12/5/2025, P120522B, Exp. Date 12/5/2024; P120822A, Exp. Date 12/8/2024; P1208228, Exp. Date 12/8/2024; P121222A, P1212228, Exp. Date 12/12/2024; P121922A, P121922B, Exp. Date 12/19/2024; P122222A, Exp. Date  12/22/2024; P122622A, P122622B, Exp. Date 12/26/2024; P010223A, Exp. Date 1/2/2025; P010423PV1, Exp. Date 1/4/2025; P010523A, P010523B, Exp. Date 1/5/2025; P010923A, Exp. Date 1/9/2025; P011123PV2, Exp. Date 1/11/2025; P011223A, P011223B, Exp. Date 1/12/2025; P011623A, Exp. Date 1/16/2025; P011823PV3, Exp. Date 1/18/2025; P011923A, P011923B, Exp. Date 1/19/2025; P012323A, P012323B, Exp. Date 1/23/2025; P012623A, Exp. Date 1/26/2025; P013023A, Exp. Date 1/30/2025; P020123A, Exp. Date 2/1 /2025; P020723A, Exp. Date 2/7/2025; P021423, Exp. Date 2/14/2025, P021623A, Exp. Date 2/16/2025; P022023A, Exp. Date 2/20/2025; P022223A, Exp. Date 2/22/2025; P022823A, Exp. Date 2/28/2025; P030123A, Exp. Date 3/1/2025; P050423A, Exp. Date 5/4/2025, P051823A, Exp. Date 5/18/2025, P052523A, Exp. Date 5/25/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0212-2023", "product_description": "GLYCERIN STERILE 99% 2ML VIAL and 5ML VIAL, Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221004@24 t20221115@20 t20221116@36", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0105-2020", "product_description": "SUCCinylcholine Chloride (PF), 200 mg/10 mL (20 mg/mL), 10 mL Fill in a 12 mL Single Dose Syringe, For IV Use Injection, Rx Only KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678416", "product_quantity": "3820 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89808", "recalling_firm": "Drug Depot, Inc., dba APS Pharmacy", "address_1": "34911 Us Highway 19 N Ste 600", "address_2": "N/A", "postal_code": "34684-1921", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA including Puerto Rico.", "recall_number": "D-0729-2022", "product_description": "(CA) GONADORELIN (4ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID136345, APS Pharmacy", "product_quantity": "1843 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20220323", "center_classification_date": "20220329", "termination_date": "20231005", "report_date": "20220406", "code_info": "Lots: 749842 BUD: 7/13/2022; 749568 BUD: 7/12/2022; 752053 BUD: 7/23/2022; 752817 BUD: 7/25/2022; 757404 BUD: 8/21/2022; 757915 BUD: 8/23/2022; 757321 BUD: 8/20/2022; 753718 BUD: 7/30/2022"}, {"status": "Terminated", "city": "Elizabeth", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA074342"], "brand_name": ["ALPRAZOLAM"], "generic_name": ["ALPRAZOLAM"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0228-2027", "0228-2029", "0228-2031", "0228-2039"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ALPRAZOLAM"], "rxcui": ["197321", "197322", "308047", "308048"], "spl_id": ["9cf12473-8eb9-4248-bfce-76eef6b82bfd"], "spl_set_id": ["a23063c0-099a-4256-b95f-3a857bbf704b"], "package_ndc": ["0228-2027-10", "0228-2027-50", "0228-2027-96", "0228-2029-10", "0228-2029-50", "0228-2029-96", "0228-2031-10", "0228-2031-50", "0228-2031-96", "0228-2039-10"], "is_original_packager": [true], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["YU55MQ3IZY"]}, "product_type": "Drugs", "event_id": "67519", "recalling_firm": "Actavis Elizabeth LLC", "address_1": "200 Elmora Ave", "address_2": "N/A", "postal_code": "07202-1106", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1153-2014", "product_description": "Alprazolam 1 mg Tablets, USP, 500 count Bottle, Rx Only , C IV, Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue Elizabeth, NJ 07207 USA, NDC 0228-2031-50", "product_quantity": "9447 Bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Complaints were received for significant tablet erosion for Alprazolam 1 mg.", "recall_initiation_date": "20140210", "center_classification_date": "20140310", "termination_date": "20140825", "report_date": "20140319", "code_info": "Lot # 1826E131, Exp 04/2015"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1650-2019", "product_description": "EDETATE CALCIUM DISODIUM 150MG/ML INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.  NDC: 70731-0934-11", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "135 vials", "code_info": "Lot #: a) Hydroxocobalamin 1000 mcg/mL 30 mL: 20130321-C, Exp 6/21/2013; 20130404-H, Exp 7/3/2013; 20130225-H, Exp 5/25/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Hydroxocobalamin Injection, all strengths and all presentations including a) Hydroxocobalamin 1000 mcg/mL 30mL and b) Hydroxocobalamin 1000 mcg/mL 10 mL P.F., Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-374-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "LAKE FOREST", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82048", "recalling_firm": "ICU Medical Inc", "address_1": "600 N FIELD DRIVE", "address_2": "", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0509-2019", "product_description": "0.9% Sodium Chloride Injection, USP 1000 mL flexible container, Rx only,  Hospira, Inc., Lake Forest, IL 60045 USA,  NDC 0409-7983-09", "product_quantity": "475320 bags", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20190204", "center_classification_date": "20190219", "termination_date": "20200604", "report_date": "20190227", "code_info": "Lot #: 91-016-JT, Exp. July 01, 2020", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90211", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0957-2022", "product_description": "Hydromorphone HCl Injection, USP, 50 mg/50 mL (1 mg/mL), 50 mL Pre-Filled Syringe, 5 x 50 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-559-50", "product_quantity": "2795 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220518", "center_classification_date": "20220527", "termination_date": "20240823", "report_date": "20220608", "code_info": "Lot: HN2005A, Exp. 9/17/2022"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-480-2013", "product_description": "Hydroxycobalamin Inj 1000mcg/ml MDV: 10 ml, 15 ml, 20 ml, 30 ml  Subcutaneous, 90 day expiration,", "product_quantity": "7", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-922-2015", "product_description": "Tetracaine (free base) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "15627 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0932-2022", "product_description": "Lipo-Mino-Mix Pyridoxine HCL (B6) 2 mg/mL Methionine 12.4 mg/mL Inositol 25 mg/mL Choline Chloride 25 mg/mL Thiamine HCL (B1) 50 mg/mL Riboflavin5P04 (B2) 5 mg/mL, Packaged as a) 10 mL Multi-Dose vial, NDC 73198-0130-10; b) 30 mL Multi-Dose vial, NDC 73198-0130-30; Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835", "product_quantity": "3762 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots:  A24103 BUD: 7/3/2022; B41B01-22 BUD: 8/1/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1207-2020", "product_description": "Clobetasol Mouth Rinse 0.05% Solution 450 mL bottle, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 bottle", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45169 Discard by: 9/2/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0704-2019", "product_description": "Dr. King's SafeCare Rx Sugar Metabolizer Men/Women, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955007227, NDC 57955-0365-2", "product_quantity": "463 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 091015J Exp. 09/18; 060216A Exp. 06/19; 091216H Exp. 09/19; 010118X Exp. 01/20"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "4650 Cases", "code_info": "Product Code: 6613; Lots: 51330, EXP 08/08/2017; 52400, EXP 10/03/2017;    53198, EXP 11/28/2017; 54582, EXP 02/27/2018; 55837, EXP 05/22/2018, 57007, EXP 08/07/2018; 57904, EXP 09/25/2018; 58931, EXP 11/06/2018.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Toothette Oral Care Suction Swabs with Perox-A-Mint solution. Contains 2 Suction Swabs with sodium bicarbonate, 0.25 fl oz/ 7ml Perox-A-Mint solution, 0.07 oz/2g Mouth Moisturizer, 1 Applicator Swab. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6613", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0390-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Monroe Township", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M001"], "brand_name": ["E-Z-GAS"], "generic_name": ["ANTACID/ANTIFLATULENT"], "manufacturer_name": ["E-Z-EM, INC."], "product_ndc": ["10361-793"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ANHYDROUS CITRIC ACID", "DIMETHICONE", "SILICON DIOXIDE", "SODIUM BICARBONATE"], "spl_id": ["f48b7c5c-d874-4779-85de-ac364816af39"], "spl_set_id": ["4e12e1cb-b033-076d-e054-00144ff8d46c"], "package_ndc": ["10361-793-01"], "is_original_packager": [true], "nui": ["N0000175833", "N0000175835", "N0000175980", "N0000008556", "N0000175089", "N0000010282"], "pharm_class_moa": ["Acidifying Activity [MoA]", "Calcium Chelating Activity [MoA]"], "pharm_class_epc": ["Calculi Dissolution Agent [EPC]", "Anti-coagulant [EPC]"], "pharm_class_pe": ["Decreased Coagulation Factor Activity [PE]", "Skin Barrier Activity [PE]"], "unii": ["XF417D3PSL", "92RU3N3Y1O", "ETJ7Z6XBU4", "8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "69389", "recalling_firm": "Bracco Diagnostic Inc", "address_1": "259 Prospect Plains Road", "address_2": "Building H", "postal_code": "08831", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0014-2015", "product_description": "E-Z- GAS II EFFERVESCENT GRANULES Antacid/Antiflatulent ,4 g (0.14 oz), 50 -count box, Rx Only, Manufactured  in USA for E-Z EM, Inc. Lake Success, NY 11042 by Tower Laboratories LTD Centerbrook, CT 06409   NDC 10361-793-01", "product_quantity": "58,050 packets", "reason_for_recall": "Subpotent Drug: Out of Specification (OOS) result during routine stability testing at 24 months.", "recall_initiation_date": "20140918", "center_classification_date": "20141009", "termination_date": "20150630", "report_date": "20141015", "code_info": "Lot # F12C01; Exp. 02/15", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-950-2015", "product_description": "Vardenafil HCl Trihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "16775 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Hastings", "state": "NE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85081", "recalling_firm": "Redline Pharmacy Solutions", "address_1": "2415 Osborne Dr E Ste 100", "address_2": "", "postal_code": "68901-1999", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Sold to patients in Nebraska", "recall_number": "D-1009-2020", "product_description": "Ertapenem in 100ML 0.9% NACL 1GM Injectable,  Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901", "product_quantity": "8 doses", "reason_for_recall": "Lack Of Processing Controls", "recall_initiation_date": "20200224", "center_classification_date": "20200312", "termination_date": "20220331", "report_date": "20200318", "code_info": "Lot 02242020@7", "more_code_info": ""}, {"status": "Terminated", "city": "Round Lake", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63189", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "Route 120 And Wilson Rd", "address_2": "N/A", "postal_code": "60073-9799", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1689-2012", "product_description": "0.9% Sodium Chloride Injection USP, packaged in a) 250 mL AVIVA Container, product code 6E1322, NDC 0338-6304-02; b) 500 mL AVIVA Container, product code 6E1323,  NDC 0338-6304-03; Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA", "product_quantity": "897,496 containers", "reason_for_recall": "Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).", "recall_initiation_date": "20120921", "center_classification_date": "20120925", "termination_date": "20150504", "report_date": "20121003", "code_info": "Lot #: a) C840892, C841007, C841403, Exp 09/12; C842377, C842757, C843748, C843946, Exp 10/12; C844332, C845065, C845198, C845347, C846873, C847301, C847608, Exp 11/12; C848481, C848937, C849554, C850180, Exp 12/12; C850966, C851097, C851212, C852459, C853044, C853614, Exp 01/13; C853747, C854455, C854711, C854836, C854943, C856013, C856138, Exp 02/13; C856948, C858027, Exp 03/13; C858712, C859066, C859199, C859389, C860569, C861021, Exp 04/13; C861856, C862953, C863076, C863183, Exp 05/13; C865188, C865824, C866178, C866178A, Exp 06/13; C867168, C868117, C868570, C868703, Exp 07/13;  b) C818187, C819367, Exp 09/12; C821686, Exp 10/12; C823377, Exp 11/12; C826255, C828111, C828228, Exp 12/12; C830455, C830604, Exp 01/13; C832964, C833152, Exp 02/13; C839134, C840587, Exp 04/13; C842740, C843649, Exp 05/13; C844647, C845941, C847038, Exp 06/13; C848184, C849117, C850545, Exp 07/13; C850842, C851568, C852806, Exp 08/13; C853853, C854216, C854216A, C855213, Exp 09/13; C856567, C858142, C858258, Exp 10/13; C858613, C859777, C859777A, C860916, Exp 11/13; C861617, C861724, Exp 12/13; C865311, C866285, Exp 01/14; C866632, C866830, Exp 02/14", "more_code_info": ""}, {"country": "United States", "city": "Baltimore", "address_1": "111 S Calvert St Fl 21ST", "reason_for_recall": "CGMP Deviation; manufacturing batch record could not be located", "address_2": "", "product_quantity": "7,215 bottles", "code_info": "lot # F602820, Expiry December 2019", "center_classification_date": "20190116", "distribution_pattern": "Product was distributed to 12 major distributors who may have further distributed the product throughout the United States.", "state": "MD", "product_description": "Cephalexin for Oral Suspension USP, 250mg/5mL, 200 mL (when mixed), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland, Manufactured by: Lupin Limited, Mandideep, India ---- NDC 68180-0124-02", "report_date": "20190123", "classification": "Class II", "openfda": {}, "recalling_firm": "Lupin Pharmaceuticals Inc.", "recall_number": "D-0380-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81898", "termination_date": "20200708", "more_code_info": "", "recall_initiation_date": "20190107", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040597"], "brand_name": ["BENZONATATE"], "generic_name": ["BENZONATATE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["68084-214"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BENZONATATE"], "rxcui": ["197397"], "spl_id": ["235a2641-ce68-1f9c-e063-6394a90ac8a7"], "spl_set_id": ["9a71725a-64b6-4800-a79c-aa4b2d74d44f"], "package_ndc": ["68084-214-11", "68084-214-01"], "original_packager_product_ndc": ["68382-247"], "nui": ["N0000009010", "N0000175796"], "pharm_class_pe": ["Decreased Tracheobronchial Stretch Receptor Activity [PE]"], "pharm_class_epc": ["Non-narcotic Antitussive [EPC]"], "unii": ["5P4DHS6ENR"]}, "product_type": "Drugs", "event_id": "70320", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave", "address_2": "Suite A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0430-2015", "product_description": "Benzonatate Capsules, USP, 100 mg, 100 count (10X10), Rx only, Packaged and Distributed by: American Health Packaging Columbus, Ohio 43217 --- NDC 68084-214-01(carton) NDC 68084-214-11 (individual dose)", "product_quantity": "2284 cartons (100 individual unit doses per carton)", "reason_for_recall": "Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules", "recall_initiation_date": "20150106", "center_classification_date": "20150401", "termination_date": "20150723", "report_date": "20150408", "code_info": "AHP lot number 145513, exp 6/2016"}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.", "address_2": "", "product_quantity": "167,712/24-caplet packages", "code_info": "Lot# 10117247  06/13  Lot# 10119336  07/13", "center_classification_date": "20140116", "distribution_pattern": "Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.", "state": "NE", "product_description": "Maximum Strength Comtrex ,Severe Cold & Sinus  Acetaminophen 325mg, Chlorpheniramine Maleate 2mg,  Phenylephrine HCL 5mg, packaged in 12 coated caplets daytime formula and 12 coated caplets nighttime formula. Novartis, distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622, NDC 0067-2081-24", "report_date": "20140122", "classification": "Class III", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-741-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65181", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130515", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "45 ml", "code_info": "All lots distributed between November 2014 and May 2015;  03122015@21, 6/10/2015; 04092015@71, 6/8/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Hydromorphone 60 mg/ml + Fentanyl 1,000 mcg/ml + Bupivacaine 10 mg/ml Intrathecal Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1676-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "209 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015; 02112015@31, 8/10/2015; 03132015@28, 9/9/2015; 03272015@5, 9/23/2015; 03262015@17, 9/22/2015; 03272015@17, 9/23/2015; 04012015@28, 9/28/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "PGE 40 (Alprostadil) 40 mcg/ml Injection, ml, Multi-Dose Vial, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1621-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Beloeil", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84055", "recalling_firm": "8046255 Canada Inc. DBA Viatrexx", "address_1": "1360 Louis-Marchand St", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed to physicians Nationwide throughout the United States and Puerto Rico.", "recall_number": "D-0347-2020", "product_description": "Viatrexx-Male+, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0400, NDC 73069-320-41.", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.", "recall_initiation_date": "20191015", "center_classification_date": "20191114", "termination_date": "20201210", "report_date": "20191120", "code_info": "Lot Numbers: 19-S00022, Exp. May: 2020"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "79062", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide within the United States", "recall_number": "D-0542-2018", "product_description": "Fentanyl Transdermal System. 75 mcg/h, packaged in 5 pouch system (NDC 0591-3213-72),  Rx Only, Manufactured by: Actavis Laboratoies UT, Inc. Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA. Individual pouch NDC 0591-3213-54.", "product_quantity": "576, 760 (5 pouches/carton)", "reason_for_recall": "Failed Impurities/Degradation Specifications: Fentanyl-n-Oxide (FNO) degradant exceeding the specification limits", "recall_initiation_date": "20180129", "center_classification_date": "20180222", "termination_date": "20180905", "report_date": "20180214", "code_info": "Lot #: 1107745A, Exp. Mar 2018;1122452A, 1137109A, Exp. Jun 2018; 1144515A, Exp. Oct 2018; 1189477A, Exp. Mar 2019; 1215224A, Exp. Aug 2019."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-854-2015", "product_description": "Prazosin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "5300 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Bronx", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "73018", "recalling_firm": "R Thomas Marketing, LLC", "address_1": "3704 White Plains Rd", "address_2": "N/A", "postal_code": "10467-5710", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide via Internet sales", "recall_number": "D-0900-2016", "product_description": "Hard Ten Days, packaged in BIG BOX (6 small boxes / 6 capsules per box / 36 capsules), Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA", "recall_initiation_date": "20160109", "center_classification_date": "20160526", "termination_date": "20190621", "report_date": "20160601", "code_info": "all lots"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0726-2023", "product_description": "heparin added to 0.9% sodium chloride, 7,500 units/1,000 mL* (7.5 units/mL), 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-7009-1.", "product_quantity": "3055 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-888668, 37-888685, 37-888701, Exp 05/02/2023; 37-890550, 37-890556, Exp 05/09/2023; 37-892201, 37-892216, Exp 05/16/2023; 37-893866, 37-893917, 37-893918, Exp 05/23/2023; 37-895705, 37-895717, Exp 05/30/2023"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1364-2022", "product_description": "AMBI Skin Cream for normal skin 2 OZ  SKU 2024219  AMBI Skin Cream for oily skin 2 OZ SKU 2024222. distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 2024219; 2024222", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70148", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-451-2015", "product_description": "Walter Reed Natl Mil Med Ctr (MD) Stock TPN D10% without Ca, Trophamine 12g, Dextrose 20g, compound vol: 200 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.", "product_quantity": "5 bags", "reason_for_recall": "Non-Sterility: Out of specification results for the sterility test for microbial contamination.", "recall_initiation_date": "20141217", "center_classification_date": "20150408", "termination_date": "20150819", "report_date": "20150415", "code_info": "lot number 37-74711, Made on 15 DEC 2014, EXP 24 DEC 2014, CAPS Rx: 37-74711-0-5-R, Disp ID: 37-1124477"}, {"status": "Terminated", "city": "Lexington", "state": "MA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68969", "recalling_firm": "Cubist Pharmaceuticals, Inc.", "address_1": "65 Hayden Ave", "address_2": "N/A", "postal_code": "02421-7994", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide   Foreign:  Israel, Taiwan", "recall_number": "D-0001-2015", "product_description": "CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6.", "product_quantity": "4,966,575 Vials", "reason_for_recall": "Presence of Particulate Matter: Potential presence of glass particulate matter in the vials.", "recall_initiation_date": "20140801", "center_classification_date": "20141001", "termination_date": "20160629", "report_date": "20141008", "code_info": "Lot #: 081753F, 081803F, 081853F, Exp 08/2014; 090103F, 090153F, 090303F, 090353F, 090403F, 090453F, 090503F, Exp 09/2014; 100503F, 100553F, 100603F, 100653F, 100703F, 100753F, 100803F, 100853F, 100903F, Exp 10/2014; 101303F, 110303F, 110353F, 110403F, 110453F,   110503F, 110603F, 110653F, 110703F, Exp 11/2014; 120303F, 120353F, 120403F, 120453F, 120503F, 120553F, 120653F, 120703F, Exp 12/2014; 140453F, Exp 02/2015; 140603F, 140653F, 140703F, 150203F, 150253F, 150303F, 150353F, 150403F, 150453F, Exp 03/2015; 160853F, 160903F,   160953F, 161003F, 161053F, 161103F, Exp 05/2015; 181003F, 181053F, 181103F, 181153F, 181603F, 181653F, 181703F, Exp 06/2015; 201503F, 201553F, 201603F, Exp 08/2015; 201753F, 210453F, Exp 09/2015; 210503F, 210553F, 210603F, 210653F, 220353F, 220403F, 220453F, Exp 10/2015; 220503F, 220553F, 220603F, 230303F, 230353F, 230403F, 230453F, 230503F, 230553F, Exp 11/2015; 240053F, 240153F, 240203F, 240253F, 240303F, Exp 12/2015; 260603F, 260653F, 260703F, Exp 02/2016; 271303F, 271353F, 271403F, 271453F, 271503F, 271553F, Exp 03/2016; 280203F, 280253F, 280303F, 280403F, Exp 04/2016; 290203F, 290303F, 290353F, Exp 06/2016."}, {"status": "Terminated", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA217116"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "product_ndc": ["70010-227", "70010-228"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310433", "310434"], "spl_id": ["3513f676-25fe-02db-e063-6294a90a1f9d"], "spl_set_id": ["e847bcfa-f3de-404a-8a57-d8a414691e6a"], "package_ndc": ["70010-227-01", "70010-227-05", "70010-228-01", "70010-228-05"], "is_original_packager": [true], "upc": ["0370010228016", "0370010227019"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "95072", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0634-2024", "product_description": "Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA NDC 70010-227-05", "product_quantity": "11,808 500-count Bottles", "reason_for_recall": "Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin Tablets", "recall_initiation_date": "20240731", "center_classification_date": "20240814", "termination_date": "20250612", "report_date": "20240814", "code_info": "Lot 1380040A, Exp. date July 31, 2025", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA017874"], "brand_name": ["TRANSDERM SCOP"], "generic_name": ["SCOPOLAMINE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["10019-008", "10019-553"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["SCOPOLAMINE"], "rxcui": ["226552", "351875"], "spl_id": ["b29f6fe1-c232-49ac-914b-29c31ab8c73d"], "spl_set_id": ["b877a694-a1d0-4280-937a-a06820b12a88"], "package_ndc": ["10019-553-03", "10019-553-04", "10019-553-90", "10019-553-06", "10019-008-10", "10019-008-24", "10019-008-01", "10019-008-04"], "is_original_packager": [true], "nui": ["N0000175574", "N0000175370"], "pharm_class_epc": ["Anticholinergic [EPC]"], "pharm_class_moa": ["Cholinergic Antagonists [MoA]"], "unii": ["DL48G20X8X"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1083-2022", "product_description": "Transderm Scop (scopolamine) Transdermanl System, 1 mg/ 3 days, 10 (patches) transdermal Systems Multipack, Rx only, MFG: Baxter Healthcare Corp, NDC 10019-553-03", "product_quantity": "56 cartons/10 patches each", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82941", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "FDA Mandated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1324-2019", "product_description": "Human Chorionic Gonadotropin 10,000 IU vials, Rx only  Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846", "product_quantity": "26 vails", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20190523", "center_classification_date": "20190607", "termination_date": "20210205", "report_date": "20190619", "code_info": "Lot #: 02052019:42 Exp. 08/03/2019"}, {"status": "Terminated", "city": "Toms River", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67810", "recalling_firm": "Pure Edge Nutrition", "address_1": "1182 Fischer Blvd Ste 3", "address_2": "N/A", "postal_code": "08753-3093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1369-2014", "product_description": "Bella Vi INSANE AMP'D Dietary Supplement capsules, 60 count bottles, www.BellaViProducts.com, distributed by Pure Edge Nutrition, LLC, Toms River, NJ", "product_quantity": "unknown", "reason_for_recall": "Marketed without an Approved NDA/ANDA; product was found to contain undeclared sibutramine & phenolphthalein", "recall_initiation_date": "20131010", "center_classification_date": "20140612", "termination_date": "20161007", "report_date": "20140618", "code_info": "lot # VINA2013 EXP: 2015/06/12"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "3513 ml", "code_info": "All lots distributed between November 2014 and May 2015;  04212015@10, 7/20/2015; 02232015@86, 5/24/2015; 02252015@79, 5/26/2015; 03112015@21, 6/9/2015; 03232015@40, 6/21/2015; 03242015@76, 6/22/2015; 03312015@60, 6/29/2015; 03272015@27, 6/25/2015; 04022015@62, 7/1/2015; 04072015@55, 7/6/2015;  04142015@59, 7/13/2015; 04212015@30, 7/20/2015; 04212015@54, 7/20/2015; 04222015@31, 7/21/2015; 05042015@64, 8/2/2015; 05052015@60, 8/3/2015; 04272015@77, 7/26/2015; 04292015@14, 7/28/2015; 04292015@23, 7/28/2015; 05052015@92, 8/3/2015; 05082015@23, 8/6/2015; 05012015@11, 7/30/2015; 05052015@98, 8/3/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "MEGA-BURN Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1696-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90512", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1280-2022", "product_description": "Anticoagulant Sodium Citrate Solution, USP 4%, 200 mg/5 mL (40 mg/mL) syringe, packaged in 5 x 5 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-906-05", "product_quantity": "85,300 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220630", "center_classification_date": "20220718", "termination_date": "20240617", "report_date": "20220727", "code_info": "Lots: SC2002A, Exp. 7/9/2022; SC2004A, Exp. 7/17/2022; SC2005A, Exp. 8/2/2022; SC2006A, Exp. 8/16/2022; SC2007A, Exp. 8/27/2022; SC2008A, Exp. 9/7/2022; SC2009A, Exp. 9/14/2022; SC2010A, Exp. 9/20/2022; SC2011A, Exp. 10/10/2022"}, {"status": "Terminated", "city": "Woodbine", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72891", "recalling_firm": "Grato Holdings, Inc.", "address_1": "201 Apple Blvd", "address_2": "N/A", "postal_code": "51579-1503", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and to Guatemala and Canada.", "recall_number": "D-0580-2016", "product_description": "Energique, Homeopathic Remedy, First Aid Pain & Trauma Relief, 1 fl oz (30 ml) bottles, NDC 44911-0135-1, Dist. by Energique, Inc., Woodbine, IA; ALSO LABELED AS --- Liddell Laboratories, First Aid Pain & Trauma Relief, Topical Homeopathic Spray, NDC 50845-0216-1, Dist By Liddell Laboratories, Inc., Woodbine, IA; and peaceful mountain, First Aid Pain & Trauma Relief, homeopathic spray, UPC 8 18692 00895 8, NDC 43846-0045-1, Dist. by Peaceful Mountain, Inc. Woodbine, IA", "product_quantity": "118 bottles", "reason_for_recall": "Microbial Contamination of Non Sterile Products; testing revealed out of specification results for total aerobic microbiological count", "recall_initiation_date": "20151222", "center_classification_date": "20160120", "termination_date": "20170310", "report_date": "20160127", "code_info": "Lot: G9471", "more_code_info": ""}, {"status": "Ongoing", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93257", "recalling_firm": "Botanical Be", "address_1": "360 Jardin Bello", "address_2": "", "postal_code": "79932-2357", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA Nationwide", "recall_number": "D-0226-2024", "product_description": "Kuka Flex Forte caplets, packaged in 30-count bottles, Manufactured by: Kukamonga, Gonzalez Ortega No 170 Col Centro, 44100 Guadalajara Jal, UPC 0736640810265", "product_quantity": "300 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.", "recall_initiation_date": "20231020", "center_classification_date": "20240112", "report_date": "20231206", "code_info": "All lots, exp 12/12/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0061-2016", "product_description": "CHORIONIC GONADOTROPIN, Injectable Solution, 4000 UNITS/ mL, 8 mL vial, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "9 vials", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t05062015@33, t08212014@16, t02032015@14"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-886-2015", "product_description": "Roxithromycin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Henderson", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80343", "recalling_firm": "Gaia Ethnobotanical LLC", "address_1": "2752 Botticelli Dr", "address_2": "", "postal_code": "89052-3107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-1006-2018", "product_description": "Gaia Kratom (mitragyna speciosa) powder,  Red Borneo, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com", "product_quantity": "unknown", "reason_for_recall": "Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination", "recall_initiation_date": "20180620", "center_classification_date": "20180726", "termination_date": "20220126", "report_date": "20180718", "code_info": "Lot # 0102031800", "more_code_info": ""}, {"status": "Terminated", "city": "Ambernath", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA200981"], "brand_name": ["METOPROLOL TARTRATE"], "generic_name": ["METOPROLOL TARTRATE"], "manufacturer_name": ["TruPharma LLC"], "product_ndc": ["52817-358", "52817-362", "52817-359", "52817-361", "52817-360"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METOPROLOL TARTRATE"], "rxcui": ["866511", "866514", "866924", "1606347", "1606349"], "spl_id": ["294dc99d-4a6d-22b6-e063-6394a90a06aa"], "spl_set_id": ["52c822f2-4a71-4ab2-a470-58074622846a"], "package_ndc": ["52817-362-10", "52817-362-00", "52817-359-10", "52817-359-50", "52817-361-10", "52817-361-00", "52817-360-10", "52817-360-00", "52817-358-10", "52817-358-50"], "is_original_packager": [true], "upc": ["0352817361103", "0352817361004", "0352817360106", "0352817362100", "0352817358509", "0352817359506", "0352817362001", "0352817360007", "0352817358103", "0352817359100"], "unii": ["W5S57Y3A5L"]}, "product_type": "Drugs", "event_id": "89311", "recalling_firm": "Rubicon Research Private Limited", "address_1": "4 & K 30 5 Plot No K 30", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one distributor who may have distributed the product further nationwide.", "recall_number": "D-0362-2022", "product_description": "Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: TruPharma, LLC. Tampa, FL 33609; Manufactured by: Rubicon Research Prvate Limited Ambernath, Dist. Thane, 421506 India. NDC 52817-360-00", "product_quantity": "3,684  1000-count bottles", "reason_for_recall": "Complaint received of foreign matter (metal) embedded in tablet.", "recall_initiation_date": "20211231", "center_classification_date": "20220107", "termination_date": "20221104", "report_date": "20220119", "code_info": "Batch # 210211H1, Exp. date FEB 2024"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "89085", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide within the United States", "recall_number": "D-0264-2022", "product_description": "Tydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg), packaged in cartons containing 3 wallets of 28 Tablets each, Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United Stated, Manufactured by: Lupin Limited, Pithampur, (M.P.) - 454775, India, 244896, The individual wallet NDC 68180-904-11 and the carton NDC 68180-904-13.", "product_quantity": "4113 cartons", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20211119", "center_classification_date": "20211201", "termination_date": "20221115", "report_date": "20211208", "code_info": "Lot #: L000784 and L000785, Exp. Date May 2022", "more_code_info": ""}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211020"], "brand_name": ["BUPROPION HYDROCHLORIDE"], "generic_name": ["BUPROPION HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["16571-862", "16571-863"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUPROPION HYDROCHLORIDE"], "rxcui": ["993541", "993557"], "spl_id": ["a047dcfb-9b8c-446e-815e-2ee800cc7b79"], "spl_set_id": ["e4f4d3fa-ddf6-4125-8486-8157efc095c1"], "package_ndc": ["16571-862-03", "16571-862-09", "16571-862-50", "16571-862-10", "16571-862-12", "16571-863-03", "16571-863-09", "16571-863-50", "16571-863-10"], "is_original_packager": [true], "upc": ["0316571862030", "0316571863037"], "unii": ["ZG7E5POY8O"]}, "product_type": "Drugs", "event_id": "93706", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0222-2024", "product_description": "buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA, NDC 16571-862-03", "product_quantity": "47,976 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules", "recall_initiation_date": "20231229", "center_classification_date": "20240111", "report_date": "20240117", "code_info": "Lot #: BPA123098A, Exp. Date 06/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89059", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0314-2022", "product_description": "NOREPINEPHRINE in 5% Dextrose Injection, 8 mg per 250 mL (32 mg per mL) Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-476-01.", "product_quantity": "1428 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211112", "center_classification_date": "20211229", "termination_date": "20231206", "report_date": "20220105", "code_info": "S21409/CCR", "more_code_info": ""}, {"status": "Ongoing", "city": "Flushing", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87712", "recalling_firm": "NSNY Distributor Inc", "address_1": "4570 192nd St", "address_2": "N/A", "postal_code": "11358-3438", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0641-2021", "product_description": "Premium OrgaZEN 7000 capsule, 1-count per blister card, distributed by: Nutra Vita Co, Santa Fe Springs, CA, Made in USA , UPC 0 40232 32555 7", "product_quantity": "2600 capsules", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/ or tadalafil", "recall_initiation_date": "20210408", "center_classification_date": "20210628", "report_date": "20210707", "code_info": "all lots"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0780-2019", "product_description": "Dr. King's SafeCare Rx Gossipy, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955225027, NDC 57955-2251-2", "product_quantity": "4 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 031016F Exp. 03/19"}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1539-2019", "product_description": "DOTS SCENTED ANTIBACTERIAL HAND GEL LIME (Ethyl Alcohol 62%), 1.35 fl oz / 40 mL, OTC, Distributed by: JFL Enterprises, Inc. Cleveland, Ohio 44102.", "product_quantity": "3852", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181022, Exp 10/21/2020"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0977-2020", "product_description": "Nicotinamide Adenine Dinucleotide (PF) Injection, NICOTINAMIDE ADENINE DINUCLEOTIDE (PF) 50 MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 10 mL Single Use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0306-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 08282019+52850, Exp 1/24/2020; 10102019+53094, Exp 2/28/2020; 10312019+53174, Exp 3/28/2020"}, {"status": "Terminated", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83190", "recalling_firm": "Pharma-Natural Inc.", "address_1": "14500 Nw 60th Ave Bldg 7f", "address_2": "N/A", "postal_code": "33014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.", "recall_number": "D-1494-2019", "product_description": "ARMY HEALTH With CURCUMIN (Menthol 3.00%) Pain Reliever Roll-On, 2.5 FL OZ (73ML) roll on bottle, Manufactured exclusively for: Crossover Telecom, LLC., P.O. Box 520248, Miami, FL 33122, UPC 8 50993 00408 6.", "product_quantity": "4981 roll on bottles", "reason_for_recall": "CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.", "recall_initiation_date": "20190621", "center_classification_date": "20190723", "termination_date": "20211027", "report_date": "20190731", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1128-2016", "product_description": "All clobetasol Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"status": "Terminated", "city": "Missoula", "state": "MT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71275", "recalling_firm": "Montana Compounding Pharmacy", "address_1": "111 N Higgins Ave", "address_2": "N/A", "postal_code": "59802-4437", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MT and ND", "recall_number": "D-1127-2015", "product_description": "Trimix (PGE1;PHENT;PAP) (N), injectable, (100/10/297) 10UG, 5 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT", "product_quantity": "2/5 mL vials", "reason_for_recall": "Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection", "recall_initiation_date": "20150515", "center_classification_date": "20150609", "termination_date": "20161220", "report_date": "20150617", "code_info": "Lot 04082015:49@7; expiry date: 6/18/2015;  Lot 04222015:25@8; expiry date: 7/3/2015."}, {"status": "Ongoing", "city": "Jersey City", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94703", "recalling_firm": "Organon Llc", "address_1": "30 Hudson St Fl 33", "address_2": "N/A", "postal_code": "07302-4804", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0552-2024", "product_description": "Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 30 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & Co. Product of Singapore. NDC 78206-0114-04", "product_quantity": "0", "reason_for_recall": "Defective Container", "recall_initiation_date": "20240528", "center_classification_date": "20240610", "report_date": "20240619", "code_info": "Lot #: Y000085, Exp 4/25/2025"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-1001-2013", "product_description": "SODIUM PHOSPHATE MONOBASIC/WATER FOR INJECTION 10%, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "01242013@5", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0582-2022", "product_description": "Children's Cherry Flavored Acetaminophen Oral Suspension (160mg/5ml), 4 FL OZ (118 mL) per bottle, Distributed by Perrigo, Allegan, MI 49010. NDC: 45802-203-26", "product_quantity": "4,176 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1GK0903, Exp 01/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0481-2022", "product_description": "Multi-Symptom Cramp Relief (acetaminophen 325mg and Pamabrom 25mg), 2- tablet packets, Mfd. for First Aid Direct, Mason, OH 45040", "product_quantity": "1,351,660 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9453, Exp. Date 01/2022; AK9716, 07/2022"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-472-2013", "product_description": "Chlorhexidine Opth Soln 0.02%, 10 ml  Opthalmic Soln, 30 day expiration,", "product_quantity": "1", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020812"], "brand_name": ["INFANTS ADVIL"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0573-0191"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["204442", "731531"], "spl_id": ["9f156faa-6bf8-483c-837d-050e40ec0cc5"], "spl_set_id": ["db5ed801-7a7e-3c83-0172-77f914daaa5a"], "package_ndc": ["0573-0191-20", "0573-0191-50", "0573-0191-22", "0573-0191-75", "0057301917", "0057301915"], "is_original_packager": [true], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "85224", "recalling_firm": "Glaxosmithkline Consumer Healthcare Holdings", "address_1": "184 Liberty Corner Rd", "address_2": "N/A", "postal_code": "07059-6796", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico.", "recall_number": "D-1067-2020", "product_description": "Ibuprofen 50 mg per 1.25 mL Oral Suspension  Advil Infant Concentrated Drops White Grape  0.75 oz. and 1 oz. bottles  NDC 0573-0191-75 (0.75 oz.)  NDC 0573-0191-50 (1 oz.)", "product_quantity": "151,056 bottles", "reason_for_recall": "Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.", "recall_initiation_date": "20200316", "center_classification_date": "20200326", "termination_date": "20211028", "report_date": "20200401", "code_info": "Batch/Lot #   R73761, exp. date 01/31/2021, Item # F00573019175, 0.75 oz.   R74936, exp. date 02/28/2021, Item # F00573019175, 0.75 oz.  R56290, exp. date 03/31/2020, Item # F00573019150, 1 oz.  R60959, exp. date 02/28/2021, Item # F00573019150, 1 oz.   R78826, exp. date 11/30/2021, Item # F00573019150, 1 oz.   9335UA, exp. date 01/31/2021, item # F00573019175A - Co-package  9336UA, exp. date 02/28/2021, item # F00573019175A - Co-package", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "120 pellets", "code_info": "All lots distributed between November 2014 and May 2015;  12112014@4, 6/9/2015; 02102015@18, 8/9/2015; 03022015@59, 8/29/2015; 03242015@96, 9/20/2015; 04292015@16, 10/26/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Estradiol 18 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1468-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Foster City", "address_1": "333 Lakeside Drive", "reason_for_recall": "Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).", "address_2": "", "product_quantity": "3,181 vials", "code_info": "Lot #: B120217A, Exp 05/15 - US Distribution", "center_classification_date": "20130516", "distribution_pattern": "Nationwide in USA, Canada, and UK (Gilead facility in Cork Ireland). Cork facility distributed to Germany/Austria, Italy and Spain.", "state": "CA", "product_description": "Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA  94404, UPC 3 61958 01011 5; NDC 61958-0101-1.", "report_date": "20130522", "classification": "Class I", "openfda": {}, "recalling_firm": "Gilead Sciences, Inc.", "recall_number": "D-324-2013", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "64267", "termination_date": "20140106", "more_code_info": "", "recall_initiation_date": "20130131", "postal_code": "94404-1147", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Dallas", "address_1": "14211 Coit Rd", "reason_for_recall": "Marketed without an approved NDA/ANDA - Product contains undeclared sibutramine, desmethylsibutramine and phenolphthalein.", "address_2": "Ste H", "product_quantity": "Unknown", "code_info": "All lots", "center_classification_date": "20160526", "distribution_pattern": "Nationwide", "state": "TX", "product_description": "Smart Lipo Dietary Supplement capsules, 900 mg, packaged in 30-count plastic bottle,  Distributed by: SmartLipo365, Arlington, TX 76011", "report_date": "20160601", "classification": "Class I", "openfda": {}, "recalling_firm": "Centro Naturista", "recall_number": "D-0878-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "71401", "termination_date": "20170330", "recall_initiation_date": "20150603", "postal_code": "75254-2862", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73336", "recalling_firm": "Walter's Pharmacy", "address_1": "401 N 17th St", "address_2": "N/A", "postal_code": "18104-5034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "PA", "recall_number": "D-0790-2016", "product_description": "Silver Nitrate 1% Ophth Solution, 5mL bottle, Rx only, Walter's Pharmacy 401 N 17th St., Allentown, PA 610-435-4706, NDC 99999-9991-92", "product_quantity": "1 bottle", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160212", "center_classification_date": "20160329", "termination_date": "20170106", "report_date": "20160406", "code_info": "Lot #012516"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0276-2021", "product_description": "Leucovorin Calcium for Injection, USP, 100 mg/vial, Single-Dose Vial, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA  92618, NDC 0703-5140-01.", "product_quantity": "248,565 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot #   31326364B, exp. date 01/2022  31327120B, exp. date 05/2022  31327963B, exp. date 10/2022"}, {"status": "Terminated", "city": "Piscataway", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA202843"], "brand_name": ["MONTELUKAST SODIUM"], "generic_name": ["MONTELUKAST SODIUM"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-726"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MONTELUKAST SODIUM"], "rxcui": ["200224"], "spl_id": ["30387eb8-222d-146e-e063-6294a90a12a7"], "spl_set_id": ["97a682c2-7e00-4d07-a5ac-4436c977f842"], "package_ndc": ["31722-726-30", "31722-726-90", "31722-726-01", "31722-726-10", "31722-726-31", "31722-726-32"], "is_original_packager": [true], "upc": ["0331722726306"], "unii": ["U1O3J18SFL"]}, "product_type": "Drugs", "event_id": "76412", "recalling_firm": "Hetero USA Inc", "address_1": "1035 Centennial Ave", "address_2": "", "postal_code": "08854-4124", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "US Nationwide", "recall_number": "D-0623-2017", "product_description": "Montelukast sodium tablets, 10 mg, 30-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: HETERO Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob  Nagar - 509 301, India, NDC 31722-726-30", "product_quantity": "65,664 bottles", "reason_for_recall": "Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle.", "recall_initiation_date": "20170107", "center_classification_date": "20170329", "termination_date": "20170808", "report_date": "20170405", "code_info": "Lot # MON16001B, Exp 01/18", "more_code_info": ""}, {"country": "United States", "city": "Bellmawr", "address_1": "136 Harding Ave", "reason_for_recall": "Labeling: Label Mixup; potentially mislabeled", "address_2": "", "product_quantity": "unknown", "code_info": "a)  Lot # 70989A; Exp. 02/18, Lot # 70973A; Exp. 01/18    b)  Lot # 70973A; Exp. 01/18, Lot # H15A76; Exp. 02/18, Lot # 71346A; Exp. 12/19, Lot # 70989A; Exp. 02/18", "center_classification_date": "20170822", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Phenobarbital Tablets USP, 100 mg, a) 100 count bottles (NDC 0463-6152-01), b) 1000 count bottles (NDC 0163-6152-10), Rx Only, Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, Distributed by Truxton, Inc., Bellmawr, NJ 08031", "report_date": "20170830", "classification": "Class II", "openfda": {}, "recalling_firm": "C. O. Truxton", "recall_number": "D-1114-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77082", "termination_date": "20180911", "more_code_info": "", "recall_initiation_date": "20170420", "postal_code": "08031-2412", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0807-2020", "product_description": "Liothyronine (T3) 80 mcg SR cap", "product_quantity": "5 bottles", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61253:42 Use by: 04/01/2020"}, {"status": "Terminated", "city": "Aiken", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67800", "recalling_firm": "GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline", "address_1": "65 Windham Blvd", "address_2": "N/A", "postal_code": "29805-9384", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1239-2014", "product_description": "Nicotine polacrilex lozenge, 4 mg, Cherry Flavor, 72 count cartons, 81 count cartons, and 108 count cartons. OTC. Labeled a. Nicorette, Distributed By: GlaxoSmithKline Consumer Healthcare, L.P., Moon Township, PA 15108.  Made in Switzerland. 72 Count NDC: 0135-0513-01, 81 Count NDC: 0135-0513-02, 108 Count NDC: 0135-0513-03 b. Nicotine Lozenge Kroger, Distributed by: The Kroger Company, Cincinnati, Ohio 45202, 72 Count NDC:30142-664-01, and c. Nicotine Walgreens, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015. 72 Count NDC: 0363-9200-01.", "product_quantity": "304,332 72 Ct Vials, 85,080 81 Ct Vials  22,992 108 Ct Vials", "reason_for_recall": "Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.", "recall_initiation_date": "20140220", "center_classification_date": "20140418", "termination_date": "20170120", "report_date": "20140430", "code_info": "Labeled A) 72 Ct Vial, Lot # 13481 (exp 5/14), 13674 (exp 5/14), 14056 (exp 2/15), 14092 (exp 3/15), 14258 (exp 7/15), 14450 (exp 10/15); 81 Ct Vial, Lot # 13855 (exp 1/15), 13927 (exp 10/14) & 14093 (exp 3/15); 108 Ct Vial, Lot # 13643 (exp 8/14) & 13992 (exp 12/14). Labeled B) 72 Ct Vial, Lot # 14041 (exp 2/15), 14117 (exp 2/15) & 14268 (exp 4/15); Labeled C) 72 Ct Vial Lot #13671 (exp 8/14) & 13890 (exp 11/14).", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0548-2021", "product_description": "Cetirizine Hydrochloride Tablets, 10 mg, 300 Count; NDC/UPC 345802919878; OTC; TABLETS", "product_quantity": "1371 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0859-2023", "product_description": "Midazolam Injection, USP, 50 mg/10mL (5mg/mL), For Intramuscular or Intravenous Use Only, 10 mL vials, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "1 vial", "code_info": "Lot #: 20180123@4, BUD 4/14/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Methionine 25mg/Inositol 50mg/Choline 50mg/ B12 1mg, 50 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0647-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA086195"], "brand_name": ["PROCTOFOAM"], "generic_name": ["PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["0037-6822"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROCORTISONE ACETATE", "PRAMOXINE HYDROCHLORIDE"], "rxcui": ["828362", "828364"], "spl_id": ["d63033a1-dca0-44f9-a6f3-210e38c2691e"], "spl_set_id": ["3831e931-ec0a-11e3-ac10-0800200c9a66"], "package_ndc": ["0037-6822-10"], "is_original_packager": [true], "unii": ["3X7931PO74", "88AYB867L5"]}, "product_type": "Drugs", "event_id": "89415", "recalling_firm": "Mylan Pharmaceuticals Inc", "address_1": "3711 Collins Ferry Rd", "address_2": "", "postal_code": "26505-2362", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Recalled product was distributed nationwide within the United States.", "recall_number": "D-0452-2022", "product_description": "Proctofoam HC (hydrocortisone acetate 1% and  pramoxine hydrochloride 1%) topical aerosol, 10 g aerosol containers, Rx Only, Distributed by Meda Pharmaceuticals Inc, Somerset, New Jersey 08873-1120,   NDC 0037-6822-10.", "product_quantity": "233,199/10 g aerosol containers", "reason_for_recall": "cGMP deficiencies", "recall_initiation_date": "20220121", "center_classification_date": "20220125", "termination_date": "20240312", "report_date": "20220202", "code_info": "Lot #: 32925, Exp. date May 2023, 33010, Exp. date June 2023; 33119, 33123, Exp. date August 2023", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86624", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one customer in PA.", "recall_number": "D-0050-2021", "product_description": "Metformin Hydrochloride Extended Release 750 mg, 30 count blister cards, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA  NDC 70518-2480-00", "product_quantity": "79/30 count blister cards", "reason_for_recall": "CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)", "recall_initiation_date": "20201011", "center_classification_date": "20201026", "termination_date": "20210224", "report_date": "20201104", "code_info": "Lot Numbers:  J0423350-121219 exp. date 12/31/2020  J0434828-020320 exp. date 02/28/2021  J0442511-031220 exp. date 03/31/2021  J0448429-040920 exp. date 04/30/2021  J0472499-081020, J0472532-081020 exp. date 08/31/2021"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0203-2019", "product_description": "Trimix ST-1 30PA-1.5PH-50A Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1388-05", "product_quantity": "40 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 05312018:12 Discard by: 11/27/2018; 07242018:04 Discard by: 1/20/2019"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0899-2019", "product_description": "People's Best Arnica Gel Homeopathic Medicine Pain Relief, Net Wt. 2.6 oz (73 g), www.kingbio.com, UPC 357955320326, NDC 57955-3203-3", "product_quantity": "1969 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 111617ZZ Exp. 11/19; 072016ZZ Exp. 07/18; 092316ZZ Exp. 09/18"}, {"status": "Terminated", "city": "Noblesville", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72177", "recalling_firm": "Pharmakon Pharmaceuticals", "address_1": "14450 Getz Rd", "address_2": "N/A", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0607-2016", "product_description": "Provocholine Pre-diluted Set II in 0.9% Sodium Chloride, 1 mg/mL, 3 mL in 5 mL Syr, injectable packed in syringes, Rx only, PHARMAKON Pharmaceuticals, Inc.", "product_quantity": "N/A", "reason_for_recall": "Stability data does not support expiry.", "recall_initiation_date": "20150819", "center_classification_date": "20160127", "termination_date": "20170509", "report_date": "20160203", "code_info": "All lots with expiration dates up to 11/17/2015"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73336", "recalling_firm": "Walter's Pharmacy", "address_1": "401 N 17th St", "address_2": "N/A", "postal_code": "18104-5034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "PA", "recall_number": "D-0794-2016", "product_description": "Acetylcysteine 10% Ophth Solution, 10mL bottle, Rx only,  Walter's Pharmacy 401 N 17th St, Allentown, PA 610-435-4706, NDC 99999-9018-33", "product_quantity": "2 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160212", "center_classification_date": "20160329", "termination_date": "20170106", "report_date": "20160406", "code_info": "Lot #: 012116, 012516"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67750", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1226-2014", "product_description": "Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL.", "product_quantity": "237,850 ampoules", "reason_for_recall": "Labeling; Missing label; ampoules are missing the immediate container label", "recall_initiation_date": "20140325", "center_classification_date": "20140408", "termination_date": "20151218", "report_date": "20140416", "code_info": "Lot: 221303A, 1OCT2014"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-477-2013", "product_description": "HCG Inj 1200un/ml MDV, 10 ml  Subcutaneous, 30 day expiration,", "product_quantity": "3", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Winter Park", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70317", "recalling_firm": "Anabolic Science Labs, LLC", "address_1": "900 S Kentucky Ave", "address_2": "N/A", "postal_code": "32789-4751", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "US Nationwide and Singapore", "recall_number": "D-0988-2015", "product_description": "ESTRASTAIN PRO-ANABOLIC MASS AND HARDENING COMPLEX (Estra-4,9,11-triene-3,17-dione 15mg, 2a-3a-epithio-17a-methyl-5a-androstan-17b-ol 10 mg), Capsules, 60 count bottle, Manufactured for: Wyked Labs LLC, Winter Park, FL 32789", "product_quantity": "12,166 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA  - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.", "recall_initiation_date": "20141212", "center_classification_date": "20150505", "termination_date": "20170208", "report_date": "20150513", "code_info": "All lots"}, {"status": "Terminated", "city": "Birmingham", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66172", "recalling_firm": "Medaus, Inc.", "address_1": "6801 Cahaba Valley Rd Ste 116", "address_2": "N/A", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1055-2013", "product_description": "NA Ascorbate 500 mg/mL, non corn PF, 100ML, Medaus Pharmacy, 1-800-526-9183", "product_quantity": "8750 mL", "reason_for_recall": "Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.", "recall_initiation_date": "20130823", "center_classification_date": "20130913", "termination_date": "20140716", "report_date": "20130925", "code_info": "LOT # 130613-8, Exp 12/10/2013", "more_code_info": ""}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0252-2016", "product_description": "Fentanyl PF 50 mL (25 mcg/mL), 10 mL Single Use Syringe, For IV, IM or SC injection, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-0002-50", "product_quantity": "711 syringes", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Numbers: 20150604@20 BUD: 10/3/2015; 20152306@20 BUD: 12/20/2015; 20152403@28 BUD: 9/20/2015"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022254"], "brand_name": ["VIMPAT"], "generic_name": ["LACOSAMIDE"], "manufacturer_name": ["UCB, Inc."], "product_ndc": ["0131-1810", "0131-2477", "0131-2478", "0131-2479", "0131-2480", "0131-5410"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LACOSAMIDE"], "rxcui": ["809974", "809984", "809987", "809990", "809992", "809994", "809996", "809998", "810000", "810002", "993856", "995156"], "spl_id": ["3cd293ae-29eb-ee01-e063-6294a90aff05"], "spl_set_id": ["9e79b42c-38a3-4b2c-a196-a5a1948250e2"], "package_ndc": ["0131-2477-35", "0131-2477-60", "0131-2477-99", "0131-2478-35", "0131-2478-60", "0131-2478-99", "0131-2479-35", "0131-2479-60", "0131-2479-99", "0131-2480-35", "0131-2480-60", "0131-2480-99", "0131-1810-67", "0131-5410-70", "0131-5410-71", "0131-5410-72"], "is_original_packager": [true], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["563KS2PQY5"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0590-2021", "product_description": "VIMPAT  (lacosamide) Tablets, 200mg, 60-count bottle, Rx Only, Manufactured for: UCB, Inc. Smyrna, GA 30080, NDC 0131-2480-35", "product_quantity": "882 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "912064"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA017697"], "brand_name": ["KINEVAC"], "generic_name": ["SINCALIDE"], "manufacturer_name": ["Bracco Diagnostics Inc."], "product_ndc": ["0270-0556"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SINCALIDE"], "rxcui": ["208236", "237982"], "spl_id": ["0d2aa8b3-2d00-f50a-c4cc-92748288e6aa"], "spl_set_id": ["1408aabb-6982-48e5-ae9f-504ec43b0003"], "package_ndc": ["0270-0556-15"], "is_original_packager": [true], "nui": ["M0004235", "N0000175798"], "pharm_class_cs": ["Cholecystokinin [CS]"], "pharm_class_epc": ["Cholecystokinin Analog [EPC]"], "unii": ["M03GIQ7Z6P"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1087-2022", "product_description": "Kinevac (Sincalide for Injection), 5mcg per vial, 10 vials per box, Rx only, MFG: Bracco Diagnostics Inc., NDC 0270-0556-15", "product_quantity": "5 boxes", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66403", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-66403-009", "product_description": "Amlodipine Besylate and Benazepril HCl Capsules, 10mg/20mg, in 100 count bottles (NDC# 0378-6898-01) and 500 count bottles (NDC# 0378-6898-05) labeled in part ***Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.***", "product_quantity": "42,174 bottles", "reason_for_recall": "CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.", "recall_initiation_date": "20130913", "center_classification_date": "20131104", "termination_date": "20150723", "report_date": "20131113", "code_info": "Lot #: a) 2003177, 2003178, 2003179, 2003180, 3043496; b) 2003176, 2003177, 3043496"}, {"country": "United States", "city": "Lake Forest", "address_1": "150 N Field Dr Ste 350", "reason_for_recall": "Subpotent Drug", "address_2": "", "product_quantity": "5808 bags", "code_info": "Lots:   192930026S Exp. 12/18/19;  192950020S Exp. 12/20/19;  192960029S Exp. 12/21/19;  192970024S Exp. 12/22/19;  193010034S Exp. 12/26/19;  193030036S Exp. 12/28/19;  193040029S Exp. 12/29/19;  193050030S Exp. 1/1/20;  193080025S Exp. 1/2/20;  193080026S Exp. 1/2/20;  193080027S Exp. 1/2/20;  193090017S Exp. 1/3/20;  193090018S Exp. 1/3/20;  193100032S Exp. 1/4/20;  193120028S Exp. 1/8/20;  193160027S Exp. 1/10/20;  193170024S Exp. 1/11/20;  193170025S Exp. 1/11/20;  193180026S Exp. 1/12/20;  193190031S Exp. 1/15/20;  193230027S Exp. 1/17/20;  193240015S Exp. 1/18/20;  193240016S Exp. 1/18/20;  193240017S Exp. 1/18/20;  193240018S Exp. 1/18/20;  193250017S Exp. 1/19/20", "center_classification_date": "20191223", "distribution_pattern": "Nationwide in the U.S.", "state": "IL", "product_description": "NORepinephrine Bitartrate 4 mg added to 250 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 254.00 mL Viaflex Bag, High Alert, Rx Only, PharMEDium Services LLC., 12620 W Airport Blvd #130 Sugar Land, TX 77478.", "report_date": "20200101", "classification": "Class III", "openfda": {}, "recalling_firm": "Pharmedium Services, LLC", "recall_number": "D-0627-2020", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "84525", "termination_date": "20210209", "more_code_info": "", "recall_initiation_date": "20191216", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA207719"], "brand_name": ["PHYTONADIONE"], "generic_name": ["PHYTONADIONE"], "manufacturer_name": ["Dr.Reddy's Laboratories Inc"], "product_ndc": ["43598-405"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["PHYTONADIONE"], "rxcui": ["1670192"], "spl_id": ["c4a2bf44-0ad2-c0d2-164f-562ba6df930c"], "spl_set_id": ["02445c07-7b4b-cd70-54e8-ebefc814f547"], "package_ndc": ["43598-405-11", "43598-405-16"], "is_original_packager": [true], "nui": ["N0000175965", "N0000175982", "M0022806", "N0000180191", "N0000175966"], "pharm_class_pe": ["Increased Prothrombin Activity [PE]", "Reversed Anticoagulation Activity [PE]"], "pharm_class_cs": ["Vitamin K [CS]"], "pharm_class_epc": ["Vitamin K [EPC]", "Warfarin Reversal Agent [EPC]"], "unii": ["A034SE7857"]}, "product_type": "Drugs", "event_id": "85231", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1094-2020", "product_description": "Phytonadione Injectable Emulsion, USP, 10 mg/mL 1 mL ampule (NDC 43598-405-11) packaged in 25 x 1 mL Single-Dose Ampules per carton (NDC 43598-405-16); Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ  08540.", "product_quantity": "10943 cartons", "reason_for_recall": "Defective Container: Recall is due to breaking and shattering of ampules upon opening", "recall_initiation_date": "20200316", "center_classification_date": "20200406", "termination_date": "20221222", "report_date": "20200408", "code_info": "Lot #: ACB902, ACB903, Exp. Date 03/2021; ACB904, Exp. Date 04/2021, ACB905, Exp. Date 06/2021"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0561-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Urinary Tract Irritations, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955505228, NDC 57955-5062-2", "product_quantity": "1443 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 033116K Exp. 03/19; 060616A Exp. 06/19; 071316L Exp. 07/19; 080315G Exp. 08/18; 111516D Exp. 11/19"}, {"status": "Ongoing", "city": "Louisville", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96853", "recalling_firm": "KABANA SKIN CARE", "address_1": "685 S Arthur Ave Unit 9b", "address_2": "N/A", "postal_code": "80027-3141", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ, FL, MI", "recall_number": "D-0515-2025", "product_description": "In Your Face Mineral Tint SPF 31, Zinc Oxide 25%, Tinted Sunscreen Broad Spectrum UVA & UVB chemical free, Organic Ingredients, Biodegradable & Baby Safe, 50 mL - 1.7 fl oz per bottle, Manufactured for IN YOUR FACE Skin Care, Belleair Bluffs, FL, Made in USA, NDC: 73369-1601-1", "product_quantity": "76 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250312", "center_classification_date": "20250710", "report_date": "20250716", "code_info": "Lot: 408-002", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "79265", "recalling_firm": "SCA Pharmaceuticals, LLC.", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "GA, NE & PA", "recall_number": "D-0603-2018", "product_description": "labetalol HCl injection 20 mg/4 mL (5mg/mL), 4 mL syringe, Rx Only, for IV Use, SCA Pharmaceuticals, Windsor, CT 06095 --- NDC 70004-0700-28, UPC 70004070028", "product_quantity": "480 syringes", "reason_for_recall": "Labeling; Incorrect or Missing Lot number/Expiration Date; some product labels incorrectly indicates a compounding date of 12/27/2018 and use-by date of 03/27/2019 instead of 12/27/2017 and use-by-date of 03/27/2018", "recall_initiation_date": "20180222", "center_classification_date": "20180319", "termination_date": "20190226", "report_date": "20180314", "code_info": "lot 1217000213, exp 03/27/2019"}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90992", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0011-2023", "product_description": "Rifampin Capsules, USP, 300 mg, packaged in a) 30-count bottle (NDC 51407-323-30), b) 60-count bottle (NDC 51407-323-60), c) 100-count bottle (NDC 51407-323-01), Rx only, Manufactured by Patheon Pharmaceuticals Inc., OH, Packaged by GSMS, Incorporated, CA.", "product_quantity": "N/A", "reason_for_recall": "Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).", "recall_initiation_date": "20221006", "center_classification_date": "20221017", "termination_date": "20250319", "report_date": "20221026", "code_info": "Lot#: a) GS041430, GS041941, Exp 1/31/2023; GS041315, GS042991, GS043027, GS043367, GS043501, GS044421, Exp 3/31/2023; b) GS041431, GS041799, GS042287, GS042414, GS042879, Exp: 1/31/2023; GS041316, GS042992, GS043368, GS043579, Exp 3/31/2023; c) GS041429, GS041877, Exp 1/31/2023; GS041317, GS043028, GS043366, GS044422, Exp 3/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077627"], "brand_name": ["TOPIRAMATE"], "generic_name": ["TOPIRAMATE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-108", "68462-153", "68462-109", "68462-110"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TOPIRAMATE"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_id": ["e06f7da2-08df-4336-82c1-fe637019c819"], "spl_set_id": ["35312f49-decf-428d-bf5f-4215b762ed3c"], "package_ndc": ["68462-108-60", "68462-108-05", "68462-108-10", "68462-153-60", "68462-153-05", "68462-153-10", "68462-109-60", "68462-109-05", "68462-109-10", "68462-110-60", "68462-110-05", "68462-110-10"], "is_original_packager": [true], "upc": ["0368462109601", "0368462153604", "0368462110607", "0368462108604"], "nui": ["N0000008486", "N0000185506", "N0000182140"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "unii": ["0H73WJJ391"]}, "product_type": "Drugs", "event_id": "64995", "recalling_firm": "Glenmark Generics Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-331-2013", "product_description": "Glenmark Topiramate Tablets, 200 mg,  60-count bottle, (NDC 68462-110-60), Rx only, Manufactured by Glenmark Generics Ltd.Colvale- Bardez Ltd 403513, India Manufactured for :  Glenmark Generics USA Mahwah, NJ 07430", "product_quantity": "9624 bottles", "reason_for_recall": "Chemical Contamination: Topiramate Tablets is being recalled due to complaints related to an off - odor. described as moldy, musty or fishy in nature.", "recall_initiation_date": "20130405", "center_classification_date": "20130516", "termination_date": "20141009", "report_date": "20130522", "code_info": "Lot# 02123782, Exp 11/14", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/110 mg may be potentially mislabeled as     BENZOCAINE/MENTHOL, LOZENGE, 15 mg/2.6 mg, NDC 63824073116, Pedigree: AD42592_4, EXP: 5/14/2014.", "address_2": "", "product_quantity": "84 Capsules", "code_info": "OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/110 mg has the following code    Pedigree: AD42584_15, EXP: 5/14/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/110 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 11523726503", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-503-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209663"], "brand_name": ["TERIFLUNOMIDE"], "generic_name": ["TERIFLUNOMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-423", "68462-424"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TERIFLUNOMIDE"], "rxcui": ["1310525", "1310533"], "spl_id": ["2b8615da-20b8-47dd-afe4-fb494392c118"], "spl_set_id": ["cb431ea0-ba0f-4b5d-a50d-f8c050762242"], "package_ndc": ["68462-423-15", "68462-423-85", "68462-423-30", "68462-424-15", "68462-424-85", "68462-424-30"], "is_original_packager": [true], "upc": ["0368462423301", "0368462424308"], "nui": ["N0000185502", "N0000185501"], "pharm_class_epc": ["Pyrimidine Synthesis Inhibitor [EPC]"], "pharm_class_moa": ["Dihydroorotate Dehydrogenase Inhibitors [MoA]"], "unii": ["1C058IKG3B"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0334-2025", "product_description": "Teriflunomide Tablets, 14mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-424-30", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232462, exp. date Nov-25"}, {"status": "Terminated", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64716", "recalling_firm": "Pallimed Solutions", "address_1": "400 W Cummings Park", "address_2": "", "postal_code": "01801-6519", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-872-2013", "product_description": "MIC with B6 and B12, compounded by Pallimed Solutions Pharmacy, Woburn, MA", "product_quantity": "18 vials", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130325", "center_classification_date": "20130809", "termination_date": "20130821", "report_date": "20130821", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Hendersonville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83997", "recalling_firm": "Basic Reset Inc.", "address_1": "260 W Main St Ste 103", "address_2": "N/A", "postal_code": "37075-7316", "voluntary_mandated": "FDA Mandated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and U.S. Virgin Islands, Canada, Nigeria, United Kingdom, Australia, Israel, Hungary, UAE, Mexico, Philippines, Greece", "recall_number": "D-0194-2020", "product_description": "Basic Reset CBD Reset 2400, True Full Spectrum Natural (unflavored), 2400 mg CBD, 1 fl. oz. (29 mL) bottle, Distributed by: Basic Reset Hendersonville, TN 37075", "product_quantity": "391 bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA", "recall_initiation_date": "20191018", "center_classification_date": "20191105", "termination_date": "20211027", "report_date": "20191113", "code_info": "Lot: 1903011.8"}, {"status": "Ongoing", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94838", "recalling_firm": "GLOBAL WIDGET LLC", "address_1": "8419 Sunstate St", "address_2": "", "postal_code": "33634-1306", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0613-2024", "product_description": "Hemp Bombs CBD Pain Freeze (menthol 4%), 100mg, 1 oz bottles, Distributed by: Global Widget 8419 Sunstate St, Tampa FL 33634, NDC 73423-003-01; UPC Code: 8-40078-56493-2", "product_quantity": "18540 bottles", "reason_for_recall": "Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.", "recall_initiation_date": "20240625", "center_classification_date": "20240722", "report_date": "20240731", "code_info": "Lot #: 230189, Exp. date Apr 2025; 230335, Exp. date Jul 2025; 230351, Exp. date Aug 2025", "more_code_info": ""}]